Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients

Annals of Surgery

Volumn 247, Issue 1, 2008, Pages 125-135

  Rees, Myrddin ^a   Tekkis, Paris P ^b   Welsh, Fenella K S ^a   O'Rourke, Thomas ^a   John, Timothy G ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASINGSTOKE PREDICTIVE INDEX; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REOPERATION; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 37549016003     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31815aa2c2     Document Type: Article

References (36)

1. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994;343:1405-1410.
2. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal cancer: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
3. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology. 1990;174:621-626.
4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309 -318.
5. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg. 1997;84:1136-1140.
6. Scheele J, Stangl R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59-71.
7. Adam R, Huguet E, Azoulay D, et al. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am. 2003;12:211-220.
8. Neeleman N, Andersson R. Repeated liver resection for recurrent liver cancer. Br J Surg. 1996;83:893-901.
9. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235:863-871.
10. Shaw IM, Rees M, Welsh FK, et al. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable longterm survival. Br J Surg. 2006;93:457-464.
11. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-657.
12. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg. 2002;137:1187-1192.
13. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291-299.
14. Schindl M, Wigmore SJ, Currie EJ, et al. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg. 2005;140:183-189.
15. Rees M, Plant G, Wells J, et al. One hundred and fifty hepatic resections: the evolution of technique towards bloodless surgery. Br J Surg. 1996;83:1526-1529.
16. Moran BJ, O'Rourke N, Plant GR, et al. Computed tomographic portography in preoperative imaging of hepatic neoplasms. Br J Surg. 1995;82:669-671.
17. Jones OM, Rees M, John TG, et al. Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg. 2005;92:1165-1168.
18. Couinaud C. Le Foie: Études Anatomiques et Chirurgicales. Paris: Masson; 1957.
19. Strasberg SM, Belghiti J, Clavien PA, et al. Terminology of liver anatomy and resections. HPB. 2000;2:333-339.
20. Basu S, Tamijmarane A, Bulters D, et al. An alternative method of wound pain control following hepatic resection: a preliminary study. HPB. 2004;6:186-189.
21. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
22. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman and Hall; 1993.
23. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
24. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
25. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460-466.
26. Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg. 1992;127:561-568.
27. Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125-7134.
28. Scheele J, Altendorf-Hofmann A, Grube T, et al. [Resection of colorectal liver metastases. What prognostic factors determine patient selection?] Chirurg. 2001;72:547-560.
29. Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668-676.
30. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982-999.
31. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46(10 suppl):S22-S31.
32. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262.
33. Tanaka K, Shimada H, Miura M, et al. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg. 2004;28:263-270.
34. Folprecht G, Grothey A, Alberts S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16:1311-1319.
35. Chung KY, Saltz LB. Antibody-based therapies for colorectal cancer. Oncologist. 2005;10:701-709.
36. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.